eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
2/2024
vol. 49
 
Share:
Send email
Share:
Clinical immunology

Changes in immune status of circulating NK cells in patients with latent tuberculosis infection

Shuang Qin
1
,
Ruiqi Chen
2
,
Meihui Li
3
,
Jiangfeng Lv
1
,
Fengmei Zhang
1
,
Yuguo Ren
1
,
Xiangyang Lin
3

  1. Department of Clinical Laboratory, Jinan People’s Hospital Affiliated to Shandong First Medical University, China
  2. Department of Tuberculosis Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, China
  3. Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, China
Cent Eur J Immunol 2024; 49 (2): 105-112
DOI: https://doi.org/10.5114/ceji.2024.142104
Online publish date: 2024/08/12
Article files
- Changes in immune (1).pdf  [1.09 MB]
- 02745_Changes in immune - Supplementary.pdf  [2.04 MB]
Get citation
 
PlumX metrics:
 
1. Getahun H, Matteelli A, Chaisson RE, Raviglione M (2015): Latent Mycobacterium tuberculosis infection. N Engl J Med 372: 2127-2135.
2. Houben RM, Dodd PJ (2016): The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Med 13: e1002152.
3. Drain PK, Bajema KL, Dowdy D, et al. (2018): Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev 31: e00021-18.
4. Boom WH, Schaible UE, Achkar JM (2021): The knowns and unknowns of latent Mycobacterium tuberculosis infection. J Clin Invest 131: e136222.
5. Colangeli R, Gupta A, Vinhas SA, et al. (2020): Mycobacterium tuberculosis progresses through two phases of latent infection in humans. Nat Commun 11: 4870.
6. Pai M, Behr M (2016): Latent Mycobacterium tuberculosis infection and interferon-gamma release assays. Microbiol Spectr 4; https://doi.org/10.1128/microbiolspec.TBTB2-0023-2016.
7. Venkatappa TK, Punnoose R, Katz DJ, et al. (2019): Comparing quantiFERON-TB gold plus with other tests to diagnose mycobacterium tuberculosis infection. J Clin Microbiol 57: e00985-19.
8. Goletti D, Delogu G, Matteelli A, Migliori GB (2022): The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. Int J Infect Dis 124 Suppl 1: S12-S19.
9. Liu CH, Liu H, Ge B (2017): Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol 14: 963-975.
10. Ruibal P, Voogd L, Joosten SA, Ottenhoff THM (2021): The role of donor-unrestricted T-cells, innate lymphoid cells, and NK cells in anti-mycobacterial immunity. Immunol Rev 301: 30-47.
11. Esin S, Batoni G (2015): Natural killer cells: a coherent model for their functional role in Mycobacterium tuberculosis infection. J Innate Immun 7: 11-24.
12. Lu CC, Wu TS, Hsu YJ, et al. (2014): NK cells kill mycobacteria directly by releasing perforin and granulysin. J Leukoc Biol 96: 1119-1129.
13. Poli A, Michel T, Thérésine M, et al. (2009): CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126: 458-465.
14. Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA (2017): The broad spectrum of human natural killer cell diversity. Immunity 47: 820-833.
15. Michel T, Poli A, Cuapio A, et al. (2016): Human CD56bright NK cells: An update. J Immunol 196: 2923-2931.
16. Cooper MA, Fehniger TA, Caligiuri MA (2001): The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640.
17. Chee CB, Sester M, Zhang W, Lange C (2013): Diagnosis and treatment of latent infection with Mycobacterium tuberculosis. Respirology 18: 205-216.
18. Salgame P, Geadas C, Collins L, et al. (2015): Latent tuberculosis infection – Revisiting and revising concepts. Tuberculosis (Edinb) 95: 373-384.
19. Albayrak N, Dirix V, Aerts L, et al. (2022): Differential expression of maturation and activation markers on NK cells in patients with active and latent tuberculosis. J Leukoc Biol 111: 1031-1042.
20. Kust SA, Streltsova MA, Panteleev AV, et al. (2021): HLA-DR-positive NK cells expand in response to Mycobacterium tuberculosis antigens and mediate mycobacteria- induced T cell activation. Front Immunol 12: 662128.
21. Prager I, Liesche C, van Ooijen H, et al. (2019): NK cells switch from granzyme B to death receptor-mediated cytoto­xicity during serial killing. J Exp Med 216: 2113-2127.
22. Qin S, Chen R, Jiang Y, et al. (2021): Multifunctional T cell response in active pulmonary tuberculosis patients. Int Immunopharmacol 99: 107898.
Copyright: © 2024 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.